Literature DB >> 27885276

Immunoregulation by members of the TGFβ superfamily.

WanJun Chen1, Peter Ten Dijke2.   

Abstract

The transforming growth factor-β (TGFβ) superfamily is encoded by 33 genes and includes TGFβ, bone morphogenetic proteins (BMPs) and activins. Although TGFβ is well recognized as a crucial regulator of immune responses, the immunoregulatory functions of other TGFβ family members are less clear. However, recent evidence suggests that BMPs and activins have important roles in regulating immune responses. In this Review, we briefly outline the signalling pathways of the TGFβ superfamily and discuss new insights into the immunoregulatory functions of BMPs and activins in the context of infection, inflammation and cancer.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27885276     DOI: 10.1038/nri.2016.112

Source DB:  PubMed          Journal:  Nat Rev Immunol        ISSN: 1474-1733            Impact factor:   53.106


  205 in total

1.  Dragon (repulsive guidance molecule b) inhibits IL-6 expression in macrophages.

Authors:  Yin Xia; Virna Cortez-Retamozo; Vera Niederkofler; Rishard Salie; Shanzhuo Chen; Tarek A Samad; Charles C Hong; Silvia Arber; Jatin M Vyas; Ralph Weissleder; Mikael J Pittet; Herbert Y Lin
Journal:  J Immunol       Date:  2010-12-27       Impact factor: 5.422

2.  TGFβ-induced early activation of the small GTPase RhoA is Smad2/3-independent and involves Src and the guanine nucleotide exchange factor Vav2.

Authors:  Elsa Papadimitriou; Dimitris Kardassis; Aristidis Moustakas; Christos Stournaras
Journal:  Cell Physiol Biochem       Date:  2011-08-16

Review 3.  The glial scar: its bearing on axonal elongation and transplantation approaches to CNS repair.

Authors:  P J Reier; J D Houle
Journal:  Adv Neurol       Date:  1988

Review 4.  The bright and the dark sides of activin in wound healing and cancer.

Authors:  Maria Antsiferova; Sabine Werner
Journal:  J Cell Sci       Date:  2012-09-18       Impact factor: 5.285

5.  TGF-beta receptor controls B cell responsiveness and induction of IgA in vivo.

Authors:  B B Cazac; J Roes
Journal:  Immunity       Date:  2000-10       Impact factor: 31.745

6.  Natural inhibitor of transforming growth factor-beta protects against scarring in experimental kidney disease.

Authors:  W A Border; N A Noble; T Yamamoto; J R Harper; Y u Yamaguchi; M D Pierschbacher; E Ruoslahti
Journal:  Nature       Date:  1992-11-26       Impact factor: 49.962

7.  The type I TGF-beta receptor engages TRAF6 to activate TAK1 in a receptor kinase-independent manner.

Authors:  Alessandro Sorrentino; Noopur Thakur; Susanne Grimsby; Anders Marcusson; Verena von Bulow; Norbert Schuster; Shouting Zhang; Carl-Henrik Heldin; Maréne Landström
Journal:  Nat Cell Biol       Date:  2008-08-31       Impact factor: 28.824

8.  Activins and inhibins: novel regulators of thymocyte development.

Authors:  Paula Licona-Limón; German Alemán-Muench; Jesus Chimal-Monroy; Marina Macías-Silva; Eduardo A García-Zepeda; Martin M Matzuk; Teresa I Fortoul; Gloria Soldevila
Journal:  Biochem Biophys Res Commun       Date:  2009-02-13       Impact factor: 3.575

9.  Adult-specific systemic over-expression reveals novel in vivo effects of the soluble forms of ActRIIA, ActRIIB and BMPRII.

Authors:  Kengo Yamawaki; Shinobu Ueda; Tsutomu Okada; Takeshi Oshima; Makoto Kakitani; Takashi Kato; Kazuma Tomizuka
Journal:  PLoS One       Date:  2013-10-21       Impact factor: 3.240

10.  Modelling human development and disease in pluripotent stem-cell-derived gastric organoids.

Authors:  Kyle W McCracken; Emily M Catá; Calyn M Crawford; Katie L Sinagoga; Michael Schumacher; Briana E Rockich; Yu-Hwai Tsai; Christopher N Mayhew; Jason R Spence; Yana Zavros; James M Wells
Journal:  Nature       Date:  2014-10-29       Impact factor: 49.962

View more
  123 in total

1.  GARP Dampens Cancer Immunity by Sustaining Function and Accumulation of Regulatory T Cells in the Colon.

Authors:  Mohammad Salem; Caroline Wallace; Maria Velegraki; Anqi Li; Ephraim Ansa-Addo; Alessandra Metelli; Hyunwoo Kwon; Brian Riesenberg; Bill Wu; Yongliang Zhang; Silvia Guglietta; Shaoli Sun; Bei Liu; Zihai Li
Journal:  Cancer Res       Date:  2019-01-23       Impact factor: 12.701

2.  Effect of Bone Morphogenetic Protein 6 on Immunomodulatory Functions of Salivary Gland-Derived Mesenchymal Stem Cells in Sjögren's Syndrome.

Authors:  Junji Xu; Yingying Su; Lei Hu; Alexander Cain; Yi Gu; Bowen Liu; Ruiqing Wu; Songlin Wang; Hao Wang
Journal:  Stem Cells Dev       Date:  2018-11-15       Impact factor: 3.272

Review 3.  Efficacy Against Human Prostate Cancer by Prostate-specific Membrane Antigen-specific, Transforming Growth Factor-β Insensitive Genetically Targeted CD8+ T-cells Derived from Patients with Metastatic Castrate-resistant Disease.

Authors:  Qiang Zhang; Brian T Helfand; Benedito A Carneiro; Weijun Qin; Ximing J Yang; Chung Lee; Weipeng Zhang; Francis J Giles; Massimo Cristofanilli; Timothy M Kuzel
Journal:  Eur Urol       Date:  2017-12-21       Impact factor: 20.096

4.  GFRAL is the receptor for GDF15 and is required for the anti-obesity effects of the ligand.

Authors:  Linda Yang; Chih-Chuan Chang; Zhe Sun; Dennis Madsen; Haisun Zhu; Søren B Padkjær; Xiaoai Wu; Tao Huang; Karin Hultman; Sarah J Paulsen; Jishu Wang; Anne Bugge; Jane Boesen Frantzen; Per Nørgaard; Jacob Fuglsbjerg Jeppesen; Zhiru Yang; Anna Secher; Haibin Chen; Xun Li; Linu Mary John; Bing Shan; Zhenhua He; Xiang Gao; Jing Su; Kristian T Hansen; Wei Yang; Sebastian Beck Jørgensen
Journal:  Nat Med       Date:  2017-08-28       Impact factor: 53.440

5.  Dual Transforming Growth Factor-β and Programmed Death-1 Blockade: A Strategy for Immune-Excluded Tumors?

Authors:  Claire Vanpouille-Box; Silvia C Formenti
Journal:  Trends Immunol       Date:  2018-03-26       Impact factor: 16.687

6.  NF-κB/MAPK activation underlies ACVR1-mediated inflammation in human heterotopic ossification.

Authors:  Emilie Barruet; Blanca M Morales; Corey J Cain; Amy N Ton; Kelly L Wentworth; Tea V Chan; Tania A Moody; Mariëlle C Haks; Tom Hm Ottenhoff; Judith Hellman; Mary C Nakamura; Edward C Hsiao
Journal:  JCI Insight       Date:  2018-11-15

7.  Activin-A limits Th17 pathogenicity and autoimmune neuroinflammation via CD39 and CD73 ectonucleotidases and Hif1-α-dependent pathways.

Authors:  Ioannis Morianos; Aikaterini I Trochoutsou; Gina Papadopoulou; Maria Semitekolou; Aggelos Banos; Dimitris Konstantopoulos; Antigoni Manousopoulou; Maria Kapasa; Ping Wei; Brett Lomenick; Elise Belaidi; Themis Kalamatas; Klinta Karageorgiou; Triantafyllos Doskas; Federica Sallusto; Fan Pan; Spiros D Garbis; Francisco J Quintana; Georgina Xanthou
Journal:  Proc Natl Acad Sci U S A       Date:  2020-05-14       Impact factor: 11.205

8.  Dural Cells Release Factors Which Promote Cancer Cell Malignancy and Induce Immunosuppressive Markers in Bone Marrow Myeloid Cells.

Authors:  Nicholas J Szerlip; Alexandra Calinescu; Eleanor Smith; Rebecca Tagett; Katrina L Clines; Henry H Moon; Russell S Taichman; Catherine H Van Poznak; Gregory A Clines
Journal:  Neurosurgery       Date:  2018-12-01       Impact factor: 4.654

Review 9.  Nutrition, inflammation and cancer.

Authors:  Laurence Zitvogel; Federico Pietrocola; Guido Kroemer
Journal:  Nat Immunol       Date:  2017-07-19       Impact factor: 25.606

Review 10.  Megakaryocytes as immune cells.

Authors:  Pierre Cunin; Peter A Nigrovic
Journal:  J Leukoc Biol       Date:  2019-01-15       Impact factor: 4.962

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.